tiprankstipranks
Advertisement
Advertisement

SDZXF Stock Latest News

Sandoz marks 20 years of Omnitrope as biosimilar savings set stage for “golden decade”
Company AnnouncementsSandoz marks 20 years of Omnitrope as biosimilar savings set stage for “golden decade”
23h ago
Sandoz investors back all AGM proposals, approve CHF 0.80 dividend
PremiumCompany Announcements
Sandoz investors back all AGM proposals, approve CHF 0.80 dividend
5d ago
Sandoz initiated with a Buy at Goldman Sachs
PremiumThe Fly
Sandoz initiated with a Buy at Goldman Sachs
13d ago
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe Fly
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
22d ago
Sandoz announces partnership agreement with Samsung Bioepis
PremiumThe Fly
Sandoz announces partnership agreement with Samsung Bioepis
27d ago
Sandoz deepens Samsung Bioepis alliance to add up to five new biosimilars
PremiumCompany AnnouncementsSandoz deepens Samsung Bioepis alliance to add up to five new biosimilars
27d ago
Sandoz Raises CHF 550 Million in Bonds and Extends USD 2 Billion Credit Line
Premium
Company Announcements
Sandoz Raises CHF 550 Million in Bonds and Extends USD 2 Billion Credit Line
1M ago
Sandoz reshapes biosimilar and generics leadership to seize upcoming patent cliff
Premium
Company Announcements
Sandoz reshapes biosimilar and generics leadership to seize upcoming patent cliff
1M ago
Sandoz price target raised to CHF 62 from CHF 55 at Berenberg
PremiumThe Fly
Sandoz price target raised to CHF 62 from CHF 55 at Berenberg
1M ago
Sandoz downgraded to Hold from Buy at Deutsche Bank
PremiumThe Fly
Sandoz downgraded to Hold from Buy at Deutsche Bank
2M ago
Sandoz downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
Sandoz downgraded to Equal Weight from Overweight at Barclays
2M ago
Sandoz lifts profit, dividend and 2026 outlook on biosimilar-driven growth
PremiumCompany Announcements
Sandoz lifts profit, dividend and 2026 outlook on biosimilar-driven growth
2M ago
Sandoz confirms E.C. granted marketing authorization for Ranluspec
PremiumThe FlySandoz confirms E.C. granted marketing authorization for Ranluspec
2M ago
Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push
Premium
Company Announcements
Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push
2M ago
Sandoz receives U.S. FDA approval to expand Enzeevu label
Premium
The Fly
Sandoz receives U.S. FDA approval to expand Enzeevu label
2M ago
Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar
PremiumCompany Announcements
Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar
2M ago
Sandoz upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Sandoz upgraded to Buy from Hold at Jefferies
2M ago
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
PremiumThe Fly
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
3M ago
Sandoz price target raised to CHF 55 from CHF 49 at Berenberg
PremiumThe Fly
Sandoz price target raised to CHF 55 from CHF 49 at Berenberg
3M ago
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
PremiumThe FlySandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
3M ago
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
Premium
Company Announcements
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
3M ago
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
Premium
Company Announcements
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >